Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus IV paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy
Kang, Y-K, Ryu, M-H, Park, S H, Kim, J G, Kim, J W, Cho, S-H, Park, Y-L, Park, S R, Rha, S Y, Kang, M J, Cho, J Y, Kang, S Y, Roh, S Y, Ryoo, B-Y, Nam, B-H, Jo, Y-W, Yoon, K-E, Oh, S CLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy055
Date:
February, 2018
File:
PDF, 642 KB
english, 2018
File converter
More search results
More benefits 
